FindTrial
Sign In

A clinical trial to Evaluate safety and efficacy of bolus dose versus fractional dose of injection hyperbaric ropivacaine (0.75%) in subarachnoid block for patients undergoing Gynaecological surgery.

Evaluation of safety and efficacy of bolus dose versus fractional dose of injection hyperbaric ropivacaine (0.75%) in subarachnoid block for patients undergoing Gynaecological surgery: Randomized double blind study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071068
Enrollment
68
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical Health Condition 3: 8- Other Procedures Health Condition 4: N858- Other specified noninflammatory disorders of uterus

Interventions

Intervention1: INJ.ROPIVACAINE (0.75%) 4ml: Bolus dose of injection hyperbaric ropivacaine (0.75%) in subarachnoid block for patients undergoing Gynaecological surgery until he effect of drug wein off

Sponsors

Kevin Dobariya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Age group of 18-60 years undergoing elective Gynaecological surgery Patient with height taller than 140cm and shorter than 180cm. Patient with BMI more than 18 or less than 25. Patients with ASA Grade I to III.

Exclusion criteria

Exclusion criteria: Contraindication of spinal Anaesthesia :local site infection, spine deformities, Coagulopathy, Severely altered mental status, increased ICP. Allergic to local anaesthetic agent.

Design outcomes

Primary

MeasureTime frame
To compare the hemodynamic changes like Pulse rate(PR), Systolic blood pressure(SBP), Diastolic blood pressure(DBP), Mean arterial pressure(MAP),Blood oxygen saturation (SpO2) in both the groups. To compare the duration of analgesia in both the groups. Timepoint: 12 months—

Secondary

MeasureTime frame
To compare the onset, peak and total duration of sensory block. To compare the onset, peak and total duration of motor block. To compare side effects and complications if any. Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr Shilpa Doshi

Government Medical College, Bhavnagar.

drshilpadoshi@yahoo.in9428810763

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026